COMMUNIQUÉS West-GlobeNewswire

Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025

11/04/2025 - 14:00

ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, [...]

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/04/2025 - 14:00

BRISBANE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement [...]

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

11/04/2025 - 14:00

SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2025 financial results on Thursday, May 8, 2025 after the market closes. [...]

Optima Health to acquire Cognate Health Limited

11/04/2025 - 13:00

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market [...]

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

11/04/2025 - 13:00

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer [...]

BON Announces Apple Polyphenol Commercial Order Signed

11/04/2025 - 13:00

XI'AN, China, April 11, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a [...]

Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy

11/04/2025 - 11:52

LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences , a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been [...]

Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals

11/04/2025 - 09:00

www.inbiome.com Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases Molecular [...]

Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

11/04/2025 - 08:30

Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) , today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda Medical [...]

Fagron publishes agenda for 2025 annual shareholders meeting

11/04/2025 - 08:00

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to [...]

CARBIOS announces fiscal-year 2024 financial results

11/04/2025 - 06:45

Cash of €109 million on December 31, 2024 PET biorecycling plant in Longlaville: adjusted schedule and confirmed intention for construction resumption once additional financing has been secured Significant progress made [...]

CARBIOS présente ses résultats annuels 2024

11/04/2025 - 06:45

Cash de 109 millions d’euros au 31 décembre 2024 Usine de biorecyclage de PET à Longlaville : calendrier ajusté et volonté confirmée pour une reprise des travaux de construction après obtention des financements [...]

Immuron Travelan® highest sales in history

11/04/2025 - 00:00

Sales Highlights (unaudited): Global Immuron exceeds AUD$5 million in sales in a fiscal year - highest sales in history March 2025 Quarter AUD$1.3 million up 2% on prior year March 2025 Year to Date AUD$5.3 million up [...]

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

10/04/2025 - 23:47

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to [...]

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/04/2025 - 23:04

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]

Passing of former Chief Executive Officer, Dr. Loressa Cole

10/04/2025 - 22:45

SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE. Loressa was a beloved [...]

Harvard Bioscience Announces CFO Transition

10/04/2025 - 22:45

HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. [...]

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

10/04/2025 - 22:33

Industry leaders gather to discuss innovative solutions for accelerating the development of therapeutics BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company [...]

Arcutis Announces Chief Financial Officer Transition

10/04/2025 - 22:30

WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]